Combination Sodium Sulfacetamide 10% and Sulfur 5% Cream With Sunscreens Versus Metronidazole 0.75% Cream for Rosacea

Article Type
Article
Changed
Thu, 01/10/2019 - 12:04
Display Headline
Combination Sodium Sulfacetamide 10% and Sulfur 5% Cream With Sunscreens Versus Metronidazole 0.75% Cream for Rosacea
Author(s)
Torok HM
Webster G
Dunlap FE
Egan N
Jarratt M
Stewart D

Article PDF
075060357.pdf
Author and Disclosure Information

Torok HM, Webster G, Dunlap FE, Egan N, Jarratt M, Stewart D

Issue
Cutis - 75(6)
Publications
Cutis
MDedge Dermatology
Topics
Rosacea
Page Number
357-363
Sections
Original Research
Author(s)
Torok HM
Webster G
Dunlap FE
Egan N
Jarratt M
Stewart D
Author(s)
Torok HM
Webster G
Dunlap FE
Egan N
Jarratt M
Stewart D
Author and Disclosure Information

Torok HM, Webster G, Dunlap FE, Egan N, Jarratt M, Stewart D

Author and Disclosure Information

Torok HM, Webster G, Dunlap FE, Egan N, Jarratt M, Stewart D

Article PDF
075060357.pdf
Article PDF
075060357.pdf

Issue
Cutis - 75(6)
Issue
Cutis - 75(6)
Page Number
357-363
Page Number
357-363
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Rosacea
Article Type
Article
Display Headline
Combination Sodium Sulfacetamide 10% and Sulfur 5% Cream With Sunscreens Versus Metronidazole 0.75% Cream for Rosacea
Display Headline
Combination Sodium Sulfacetamide 10% and Sulfur 5% Cream With Sunscreens Versus Metronidazole 0.75% Cream for Rosacea
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis

Article Type
Article
Changed
Thu, 01/10/2019 - 11:57
Display Headline
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Author(s)
Jorizzo J
Stewart D
Bucko A
Davis SA
Espy P
Hino P
Rodriguez D
Savin R
Stough D
Furst K
Connolly M
Levy S

Article PDF
070060335.pdf
Author and Disclosure Information

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Issue
Cutis - 70(6)
Publications
Cutis
MDedge Dermatology
Topics
Nonmelanoma Skin Cancer
Melanoma
Page Number
335-339
Sections
Original Research
Author(s)
Jorizzo J
Stewart D
Bucko A
Davis SA
Espy P
Hino P
Rodriguez D
Savin R
Stough D
Furst K
Connolly M
Levy S
Author(s)
Jorizzo J
Stewart D
Bucko A
Davis SA
Espy P
Hino P
Rodriguez D
Savin R
Stough D
Furst K
Connolly M
Levy S
Author and Disclosure Information

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Author and Disclosure Information

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S

Article PDF
070060335.pdf
Article PDF
070060335.pdf

Issue
Cutis - 70(6)
Issue
Cutis - 70(6)
Page Number
335-339
Page Number
335-339
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Nonmelanoma Skin Cancer
Melanoma
Article Type
Article
Display Headline
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Display Headline
Randomized Trial Evaluating a New 0.5% Fluorouracil Formulation Demonstrates Efficacy After 1-, 2-, or 4-Week Treatment in Patients With Actinic Keratosis
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Stewart D